• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sai Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 68121.0
  • ISIN : INE570L01029
1,785.10 191 (11.95%)
  • As on 06 Nov 2026 (EOD)

  • Today’s Low

    1,614.90

  • Today’s High

    1,814.90

  • Open

    1,655.10

  • Perv Close

    1,594.50

  • 52W Low

    783.85

  • 52W High

    1,814.90

Key Indicators

  • P/E(TTM)

    105.25

  • Mar.Cap (₹Cr.)

    37,928.51

  • Div & Yield %

    0.00

  • Book Value(₹)

    118.04

  • Debt-Equity Ratio

    11.95

  • AGM Date

    06-Nov-2026

  • EPS

    16.96

  • P/E Ratio

    105.25

Financials Ratios

  • Debt-Equity Ratio

    0.87

  • Mar.Cap (₹Cr.)

    37,928.51

  • RONW (%)

    8.89

  • ROCE (%)

    10.56

Score Board

  • Equity (₹ in Cr.)

    21.25

  • BV (₹)

    118.00

  • Sales( ₹ in Cr.)

    2,153.23

  • NP (in Cr.)

    348.19

  • NP Var(%)

    99.0

  • Div%

    0.0

  • CPS (₹)

    23.60

  • EPS (₹)

    16.40

  • Traded Value (₹ in Lakhs)

    33,914.90

  • 52 Week High

    1,814.90

  • 52 Week Low

    783.85

  • Price BSE

    1596.0

  • Price NSE

    1,595.00

  • Market Capital( in Cr.)

    33,914.90

  • P/C Ratio

    67.80

  • P/E Ratio

    97.40

  • Price Vs.BV

    16.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,153.23 1,642.05 1,418.68 1,157.40 841.02 751.47
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,153.23 1,642.05 1,418.68 1,157.40 841.02 751.47
Other Income 49.13 37.34 29.33 27.96 28.15 27.29
Stock Adjustments 7.76 -4.13 -23.80 4.59 2.83 16.50
Total Income 2,210.12 1,675.26 1,424.21 1,189.95 872.00 795.26
EXPENDITURE :            
Raw Materials 568.34 445.52 408.78 413.12 251.14 232.69
Power and Fuel Cost 64.63 48.19 49.49 43.73 31.86 27.25
Employee Cost 617.73 485.56 430.63 353.76 263.37 203.64
Other Manufacturing Expenses 130.01 95.35 84.73 90.06 78.21 50.32
Selling and Administration Expenses 199.80 135.20 117.15 84.16 84.59 85.45
Miscellaneous Expenses -12.93 35.76 16.06 10.29 9.79 4.44
Employee Benefit Expenses 617.73 485.56 430.63 353.76 263.37 203.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,567.57 1,245.57 1,106.84 995.11 718.97 603.79
Operating Profit 642.55 429.69 317.37 194.84 153.03 191.46
Interest 34.08 71.94 81.15 74.38 50.98 32.11
Gross Profit 608.47 357.75 236.22 120.46 102.05 159.35
Depreciation 152.30 126.03 107.21 87.77 79.70 71.77
Profit Before Tax 456.17 231.72 129.01 32.69 22.35 87.58
Current Tax 87.95 33.82 7.97 10.73 9.37 3.73
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 26.74 24.44 25.81 -2.28 -2.70 18.55
Reported Net Profit 341.48 173.46 95.23 24.24 15.68 65.30
Extraordinary Items -6.71 -1.36 0.01 -0.38 11.31 0.00
Adjusted Net Profit 348.19 174.82 95.22 24.62 4.37 65.30
Adjustment below Net Profit 1.26 0.95 1.08 2.39 0.00 0.83
P & L Balance brought forward 768.46 594.05 497.75 478.02 461.76 394.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 6.90 -0.58 -0.21
P & L Balance carried down 1,111.21 768.46 594.05 497.75 478.02 460.57
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 383.30 396.30 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 38.33 39.63 0.00
Earnings Per Share-Unit Curr 16.12 8.32 53.92 13.76 8.93 36.65
Earnings Per Share(Adj)-Unit Curr 16.12 8.32 - - - -
Book Value 118.42 104.00 572.28 517.79 507.50 486.92
Book Value(Adj)-Unit Curr 118.42 104.00 - - - -

Shareholding Pattern

  • Promoter Group

    34.50%

  • Public Share Holding

    65.50%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 3,521,560 3,521,560.00 3,521,560 3,521,560
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,521,560 1.66 3,521,560 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,199,905 5.27 11,199,905 4
Partnership Firms-Indian (Promoter & Group) 58,573,210 27.57 58,573,210 6
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 69,773,115 32.85 69,773,115 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 42,296,927 19.91 42,296,927 205
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,627,091 2.65 5,627,091 10
Mutual Funds / UTI 62,796,845 29.56 62,796,845 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 238,185 0.11 238,185 19
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 110,959,048 52.24 110,959,048 265
2] Non Institution
Bodies Corporate 1,529,598 0.72 1,529,598 542
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 1,201,840 0.57 1,180,340 40
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 8,356,036 3.93 8,356,036 2,373
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 424,753 0.20 424,753 3,543
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,629,254 2.18 4,629,254 10
Individuals holding nominal share capital up to Rs. 1 lakh 10,686,768 5.03 10,686,768 136,331
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 201,169 0.09 201,169 6
Others 1,135,075 0.53 1,135,075 2
Sub Total 28,164,493 13.26 28,142,993 142,847
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 212,418,216 100.00 212,396,716 143,124

Company Background

Sai Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sai Life Sciences Ltd
  • BSE Code : 68121.0
  • ISIN : INE570L01029

  • Incorporation Year

    1999

  • Registered Office

    Plot #.DS-7 IKP Knowledge Park
    Turkapally (V) Shameerpet Md, Hyderabad,
    Telangana-500078

  • Telephone

    +91 40 6815 6000

  • FAX

  • Chairman

    Ranga Raju Kanumuri

  • Managing Director

    Krishnamraju Kanumuri

  • Company Secretary

    RUNA KUMAR

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Sai Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sai Life 1,785.00 2,202.36 2,153.23 107.01 18.71
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77